Overcoming Racial Distrust, Spirituality and Cultural Decision Making at the End of Life
Dr. RR Baliga's 'Podkast for the Kurious Doc'
Release Date: 06/10/2020
Stent. Relieve. Revive: EVT Rewrites the Story of Post-Thrombotic Syndrome 🩺⚡
Dr. RR Baliga's 'Podkast for the Kurious Doc'
A thoughtful, practice-shaping study in NEJM explores a long-standing clinical dilemma: can we truly move the needle in post-thrombotic syndrome? The C-TRACT trial shows that endovascular therapy (iliac-vein stenting) significantly improves symptom burden and quality of life in patients with moderate–severe disease—measured rigorously using VCSS, VEINES-QOL, and SF-36. The magnitude of benefit is clinically meaningful. But every intervention casts a shadow. 👉 Bleeding risk was ~3-fold higher, largely driven by intensified antithrombotic therapy. 👉 Durability...
info_outline
Coach & Conquer Hypertension with Team-Based Care
Dr. RR Baliga's 'Podkast for the Kurious Doc'
A landmark study in the New England Journal of Medicine shows that hypertension control is no longer just about prescribing medications—it’s about systems, teams, and sustained engagement. 🩺📊 In a cluster-randomized trial across underserved populations, a multifaceted, team-based strategy—combining protocol-driven care, health coaching, and home BP monitoring—achieved a significant additional reduction of −6.4 mm Hg in systolic BP (P<0.001) and improved adherence. The message is clear: 👉 Evidence works—but only when implemented well 👉 Teams outperform...
info_outline
Hormones. Vessels. Clots 🧬
Dr. RR Baliga's 'Podkast for the Kurious Doc'
Sex hormones shape cardiovascular risk in subtle yet powerful ways. From estrogen-driven changes in coagulation to formulation-specific differences in VTE risk, the nuance matters. Transdermal estradiol offers a safer path, while ethinyl estradiol reminds us that dose and route are destiny. The key is not avoidance—but precision: matching therapy to individual risk. Three takeaways: • Formulation matters • First year matters • Patient factors matter #Cardiology #Thrombosis #PrecisionMedicine #HormoneTherapy
info_outline
From Regurgitation to Restoration: 🔄 The TTVR Revolution Redefines Tricuspid Therapy
Dr. RR Baliga's 'Podkast for the Kurious Doc'
A landmark study on transcatheter tricuspid valve replacement (TTVR) offers compelling real-world evidence 🫀 ✅ 98.4% procedural success ✅ Near-complete TR elimination (97.7% at 30 days) ✅ Significant improvement in symptoms & quality of life ⚠️ Trade-off: ~16% new pacemaker rate in device-naïve patients In an elderly, high-risk cohort, TTVR delivers what surgery often cannot—restoration without incision, relief without delay. A meaningful step forward in structural heart disease—where the right heart finally takes center stage ✨
info_outline
Stroke. Safety. Strategy: The Factor XIa Revolution 🚀🧠
Dr. RR Baliga's 'Podkast for the Kurious Doc'
A quiet shift, yet a profound one. 🧠 The OCEANIC-STROKE trial introduces asundexian, a Factor XIa inhibitor that lowers recurrent ischemic stroke risk (HR 0.74) without increasing major bleeding—a long-sought balance in antithrombotic therapy. For decades, we traded efficacy for safety. Now, we may finally have both. ⚖️ The implications extend beyond stroke—to a broader rethinking of thrombosis itself: can we uncouple clot from bleed? This study suggests we can. #StrokePrevention #Cardiology #Neurology #ClinicalTrials #Anticoagulation...
info_outline
Seeds. Signals. Sanctuary: The Biology of Brain Metastases 🧠
Dr. RR Baliga's 'Podkast for the Kurious Doc'
🧠 Brain metastases remain a clinical frontier—common, complex, and still lethal. In Science Signaling, Chafe et al. unpack the biology: Blood Brain Barrier traversal, metabolic rewiring, and immune evasion. Key insight: metastasis is not just spread—it is adaptation. From adenosine-driven immunosuppression to neuronal-like tumor states, new therapeutic doors are opening. Precision oncology must now think beyond the primary tumor. #BrainMetastases #Oncology #NeuroOncology #Immunotherapy #PrecisionMedicine
info_outline
Great Doctors Series: 🎙️ Sushruta: Scalpel. Science. Soul 🩺✨
Dr. RR Baliga's 'Podkast for the Kurious Doc'
What if the roots of modern surgery were written over 2,000 years ago? 🩺📜 Meet —a pioneer whose Suśruta Saṃhitā laid the foundations of plastic surgery, cataract procedures, and structured medical training. From rhinoplasty to hands-on simulation using natural models, his approach was remarkably ahead of its time. A reminder that innovation is often rediscovery—and that the future of medicine is deeply anchored in its past. 🌍✨ #HistoryOfMedicine #Ayurveda #Surgery #MedicalEducation #Innovation
info_outline
Stop. Test. Rethink: The Thyroxine Turning Point 🔄🧠💊
Dr. RR Baliga's 'Podkast for the Kurious Doc'
🧠💊 Stop. Test. Rethink. A compelling new study in JAMA shows that ~26% of adults ≥60 years can safely discontinue levothyroxine, maintaining normal thyroid function—especially those on low doses (≤50 μg/day). 📉 No meaningful decline in quality of life 📊 Clear dose-response signal ⚠️ Raises concerns about lifelong overtreatment The message is elegant: Not every prescription deserves permanence. Time to reassess, deprescribe, and individualize—particularly in our older patients. #Thyroid #Endocrinology #Deprescribing #Geriatrics...
info_outline
Reversing Heart Failure: Where immunology meets cardiology
Dr. RR Baliga's 'Podkast for the Kurious Doc'
A fascinating step forward in Nature—where immunology meets cardiology. 🧬❤️ This study shows that engineered dendritic cells can locally reprogram the immune response, reduce fibrosis, and improve cardiac function—without systemic immunosuppression. The insight is simple, yet profound: 👉 Heart failure is not just hemodynamic—it is immunologic. From FAP-targeted delivery to checkpoint-mediated tolerance (PD-L1, CTLA4-Ig, IL-10), this work opens the door to a new therapeutic paradigm—precision immunotherapy for heart failure. 🚀 The seeds of...
info_outline
Chronology vs Physiology: A Clinical Reckoning ⚖️❤️🩹
Dr. RR Baliga's 'Podkast for the Kurious Doc'
🧠⏳ Age. Biology. Truth. A compelling Perspective in the New England Journal of Medicine challenges one of medicine’s quiet assumptions: that age equals risk. Two patients may share a birth year—but not a biology. From epigenetic clocks to physiological reserve, the evidence is clear: chronologic age is an imperfect proxy for clinical decision-making ⚠️ The consequence? Missed prevention in the young, withheld therapy in the old. ✨ The opportunity? A shift toward biologically grounded, precision care—where treatment aligns not with years lived,...
info_outlineOvercoming Racial Distrust, Spirituality and Cultural Decision Making at the End of Life
Dr RR Baliga's 'GOT KNOWLEDGE DOC' PodKasts for Physicians
PodKast derived from
book chapter authored by
Dr Horace M DeLisser, MD
Associate Dean for Diversity & Inclusion
Perelman School of Medicine
University of Pennsylvania
Baliga's Textbook of Internal Medicine
www.MasterMedFacts.com